FDA Questions and Answers: Angiotensin II Receptor Blocker Recalls
November 19, 2018 – The U.S. FDA has published a new resource online to answer questions about recent recalls of angiotensin II receptor blocker (ARB) products. The recalls to date have only affected generic drugs that contain valsartan, irbesartan, or losartan active pharmaceutical ingredients (APIs). The affected medications contained APIs with N-Nitrosodimethylamine (NDMA) or N-Nitrosodiethylamine (NDEA) impurities.
The new resource, which contains comprehensive information on the history and nature of 2018’s ARB recalls, is available at: